EICHORCondition: COVID-19 · Sponsor: Novavax
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary doses of SARS-CoV-2 rS with Matrix-M™ adjuvant (NVX-CoV2373) given 21 days apart and NVX CoV2373 or a variant-based vaccine given as a booster dose or at crossover in pediatric participants (3 age cohorts; 6 to \< 12 years, 2 to \< 6 years, and 6 to \< 24 months of age). Each age cohort will be conducted in 2 parts starting with the oldest age cohort (6 to \< 12 years of age).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Preferred Research Partners, Inc. | Little Rock, Arkansas, United States | — |
| Advanced Research Center | Anaheim, California, United States | — |
| Coast Clinical Research, LLC | Bellflower, California, United States | — |
| Apex Research Group | Fair Oaks, California, United States | — |
| Ark Clinical Research | Long Beach, California, United States | — |
| Orange County Research Institute | Ontario, California, United States | — |
| California Research Foundation | San Diego, California, United States | — |
| Clinical Research of California | Walnut Creek, California, United States | — |
| Imagine Research of Palm Beach County | Boynton Beach, Florida, United States | — |
| Palm Harbor Dermatology PA | Brandon, Florida, United States | — |
| Westside Center for Clinical Research | Jacksonville, Florida, United States | — |
| Cordova Research Institute, LLC | Miami, Florida, United States | — |
+ 82 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05468736